Who is sponsoring NCT03858673?

NCT03858673 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT03858673?

Interventions in NCT03858673: VTH via the Tsuzi method with residual uterine ligament ligation.

What condition does NCT03858673 study?

NCT03858673 studies Vault Prolapse, Vaginal.

Is NCT03858673 still recruiting?

NCT03858673 is currently completed. Last updated 6 March 2019.

Last reviewed 2019-03-06 · How we verify

NCT03858673

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of PHVP of Different VTH Methods

Completed Last updated 6 March 2019

What this trial tests

trial testing VTH via the Tsuzi method with residual uterine ligament ligation in Vault Prolapse, Vaginal in 213 participants. Completed in 31 December 2017.

Timeline

1 January 1986

Primary endpoint
31 December 2001

31 December 2017

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	213
Start date	1 January 1986
Primary completion	31 December 2001
Estimated completion	31 December 2017

Drugs / interventions tested

VTH via the Tsuzi method with residual uterine ligament ligation

Conditions studied

Vault Prolapse, Vaginal — all drugs for Vault Prolapse, Vaginal →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 85, female only, with Vault Prolapse, Vaginal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the post-hysterectomy vault prolapse (PHVP) rates performed using different methods of vaginal total hysterectomy (VTH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Vault Prolapse, Vaginal

Currently open trials in the same condition.

NCT06524700 — Pectopexy Autologous Vs Mesh · NA · active not recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03858673 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 6 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03858673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing